Get the full picture
Sign in to uncover key details.
Monimoi Therapeutics
Manufacturing · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
40 Guest St, Brighton, Massachusetts, 02...Website
www.monimoitx.comRevenue
<$5 MillionIndustry
About Monimoi Therapeutics
Monimoi Therapeutics is a Boston, Massachusetts-based biotechnology company, founded in 2025, that develops transformative cancer therapies by integrating chemical proteomics, covalent-based molecular technologies, and translational insights from patients. The company targets high-value, hard-to-drug cancer-promoting proteins to create durable treatments and overcome resistance to existing therapies, widening the landscape of druggable targets in oncology. Backed by investors including Catalio Capital Management, Mass General Brigham Ventures, Regeneron Ventures, and The Column Group, Monimoi Therapeutics is led by a team combining academic founders and experienced biotech industry leadership.Explore more
SIC Code 28,283NAICS Code 32,325Show moreMonimoi Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Monimoi Therapeutics
Sign Up For FreeTo access detailed company insights
Monimoi Therapeutics is a Boston, Massachusetts-based biotechnology company, founded in 2025, that develops transformative cancer therapies by integrating chemical proteomics, covalent-based molecular technologies, and translational insights from patients. The company targets high-value, hard-to-drug cancer-promoting proteins to create durable trea... Read More
